Drawing for ERGENTIA

USPTO serial 88791385

ERGENTIA

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
BECHHOFER, YOCHEVED D
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ERGENTIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of pain, cardiovascular diseases, respiratory diseases, central nervous system disorders, gastrointestinal diseases, and metabolic syndrome; Pharmaceutical preparations, namely, anti-viral agents, immunosuppressant agents, and corticosteroids; pharmaceutical preparations for use in oncology and endocrinology; pharmaceutical preparations for use in women's health, namely, for the treatment of breast cancer and post-menopausal symptoms; oral contraceptivesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 25, 2020MAB5ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION—
Aug 25, 2020ABN5ABANDONMENT - AFTER PUBLICATION—
Aug 17, 2020EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Aug 7, 2020ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jul 14, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 14, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 24, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 9, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 27, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 27, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 27, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 18, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 18, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 18, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 16, 2020DOCKASSIGNED TO EXAMINER—
Feb 14, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 13, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance